|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.5 SEK | +3.96% |
|
+3.96% | -29.53% |
| 30/04 | Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 14/02 | Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Corline Biomedical AB reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 5.57 million compared to SEK 10.2 million a year ago. Revenue was SEK 5.64 million compared to SEK 10.21 million a year ago.
Net loss was SEK 1.67 million compared to net income of SEK 1.02 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.53% | 20.28M | |
| +10.23% | 9.11B | |
| -10.76% | 5.21B | |
| +51.58% | 4.83B | |
| +12.50% | 4.09B | |
| -20.70% | 2.35B | |
| +12.83% | 2.32B | |
| +19.51% | 2.27B | |
| -29.65% | 2.19B | |
| -0.50% | 1.64B |
CORLINE BIOMEDICAL AB 
